Back to top
more

Veru (VERU)

(Delayed Data from NSDQ)

$0.37 USD

0.37
2,273,117

0.00 (-0.11%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $0.37 0.00 (-0.72%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (155 out of 244)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's What Could Help Veru Inc. (VERU) Maintain Its Recent Price Strength

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Veru Inc. (VERU) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Equity Research

Veru Inc. (VERU) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Veru Inc. (VERU) delivered earnings and revenue surprises of 27.27% and 17.99%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Can Veru Inc. (VERU) Climb 344% to Reach the Level Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 343.6% upside potential for Veru Inc. (VERU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Earnings Preview: Veru Inc. (VERU) Q1 Earnings Expected to Decline

by Zacks Equity Research

Veru Inc. (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Veru (VERU) Up on FDA's Fast Track Tag for Breast Cancer Drug

by Zacks Equity Research

The FDA bestows a Fast Track designation to Veru's (VERU) phase III program evaluating enobosarm for treating AR+ER+HER2- metastatic breast cancer. Shares rise.

Zacks Equity Research

OrganiGram (OGI) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

OrganiGram (OGI) delivered earnings and revenue surprises of 0% and 3.44%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Veru Inc. (VERU) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Veru Inc. (VERU) delivered earnings and revenue surprises of 37.50% and 14.32%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Veru Inc. (VERU) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Veru Inc. (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Veru Inc. (VERU) delivered earnings and revenue surprises of 50.00% and 26.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Veru Inc. (VERU) Q3 Earnings Expected to Decline

by Zacks Equity Research

Veru Inc. (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Veru Inc. (VERU) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Veru Inc. (VERU) delivered earnings and revenue surprises of -33.33% and -7.12%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Why Veru (VERU) Might Surprise This Earnings Season

by Zacks Equity Research

Veru (VERU) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

Veru Inc. (VERU) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Veru Inc. (VERU) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Will Top-Line Growth Buoy Motorola's (MSI) Q1 Earnings?

by Zacks Equity Research

With a healthy demand across land mobile radio products and other devices, Motorola Solutions (MSI) is likely to have generated higher consolidated revenues in Q1 despite the coronavirus-led turmoil.

Zacks Equity Research

Are Options Traders Betting on a Big Move in Veru (VERU) Stock?

by Zacks Equity Research

Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.

Zacks Equity Research

Veru (VERU) Reports Q1 Loss, Tops Revenue Estimates (Revised)

by Zacks Equity Research

Veru (VERU) delivered earnings and revenue surprises of 50.00% and 37.56%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Female Health Company The (VERU) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Female Health Company The (VERU) delivered earnings and revenue surprises of 50.00% and 37.56%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Female Health Company The (VERU) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Female Health Company The (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Implied Volatility Surging for Veru (VERU) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.

Zacks Equity Research

Do Options Traders Know Something About Veru (VERU) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.

Zacks Equity Research

Do Options Traders Know Something About Veru (VERU) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.

Zacks Equity Research

Veru (VERU) Soars: Stock Adds 6.9% in Session

by Zacks Equity Research

Veru (VERU) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for January 29th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 29th

Zacks Equity Research

Will Veru Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Veru.

Zacks Equity Research

Will Veru Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Veru.